Mutations of the RBD that evade vaccinal immunity (which was long known): https://doi.org/10.1016/j.cell.2021.04.006 https://doi.org/10.1016/j.cell.2021.04.006

Mutations of the RBD that evade vaccinal immunity (which was long known): https://doi.org/10.1016/j.cell.2021.04.006 https://doi.org/10.1016/j.cell.2021.04.006 https://doi.org/10.1016/j.cell.2021.03.013 https://doi.org/10.1016/j.cell.2021.03.013 Feasibility argument based on molecular modelling: https://doi.org/10.1016/j.jinf.2021.08.010 https://doi.org/10.1016/j.jinf.2021.08.010 Infection-enhancing antibody pathways exist: https://doi.org/10.1016/j.cell.2021.06.021 https://doi.org/10.1016/j.cell.2021.06.021